U.S. markets close in 5 hours 23 minutes
  • S&P 500

    3,960.00
    -38.84 (-0.97%)
     
  • Dow 30

    33,768.13
    -178.97 (-0.53%)
     
  • Nasdaq

    11,085.39
    -154.55 (-1.37%)
     
  • Russell 2000

    1,827.51
    -12.71 (-0.69%)
     
  • Crude Oil

    75.94
    -0.99 (-1.29%)
     
  • Gold

    1,785.50
    +4.20 (+0.24%)
     
  • Silver

    22.45
    +0.03 (+0.15%)
     
  • EUR/USD

    1.0494
    -0.0003 (-0.03%)
     
  • 10-Yr Bond

    3.5660
    -0.0330 (-0.92%)
     
  • GBP/USD

    1.2163
    -0.0031 (-0.25%)
     
  • USD/JPY

    136.6400
    -0.0450 (-0.03%)
     
  • BTC-USD

    16,988.87
    -92.67 (-0.54%)
     
  • CMC Crypto 200

    400.45
    -1.36 (-0.34%)
     
  • FTSE 100

    7,543.24
    -24.30 (-0.32%)
     
  • Nikkei 225

    27,885.87
    +65.47 (+0.24%)
     

Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression

Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression

Eisai and Biogen BIIB said Wednesday that their drug, lecanemab, reduced cognitive and functional decline by 27%, compared with a placebo, over 18 months in a Phase 3 study of 1,800 patients with early-stage Alzheimer's.